Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunityYared Hailemichael, Adi Diab, Alexander J. Lazar et al.|Cancer Cell|2022Cited by 338
An ERK5-NRF2 Axis Mediates Senescence-Associated Stemness and AtherosclerosisJun‐ichi Abe, Sivareddy Kotla, Masaki Imanishi et al.|Circulation Research|2023Cited by 39
Anti-tumor immunity induced by ectopic expression of viral antigens is transient and limited by immune escapeNeeraja Dharmaraj, Simon Young, Stacey L. Piotrowski et al.|OncoImmunology|2019Cited by 33
Interleukin-6 Blockade Abrogates Immunotherapy Toxicity and Promotes Tumor ImmunityYared Hailemichael, Adi Diab, Daniel H. Johnson et al.|SSRN Electronic Journal|2021Cited by 24
Reevaluating Anti-Inflammatory Therapy: Targeting Senescence to Balance Anti-Cancer Efficacy and Vascular DiseaseBernardo Casso-Chapa, Jun‐ichi Abe, Nerea González et al.|Arteriosclerosis Thrombosis and Vascular Biology|2025Cited by 3